Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07483047

Prediction Model for Postoperative Cognitive Dysfunction in Elderly Cardiac Patients: A Special Disease Cohort Study

This is a prospective cohort study aiming to construct a prediction model for postoperative cognitive dysfunction (POCD) in elderly cardiac patients. We plan to enroll elderly patients aged ≥65 years undergoing cardiac surgery. Peripheral blood samples and functional magnetic resonance imaging (fMRI) data will be collected at baseline and key time points post-surgery. The primary objectives are to identify novel peripheral blood protein biomarkers for POCD, explore the correlation between fMRI characteristics and POCD, and establish a reliable early prediction model to improve perioperative management and reduce the incidence of POCD in elderly cardiac surgical patients.

Recruiting

Interested in participating?

Request Info

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Shanghai Geriatric Medical Center

Shanghai, China

Location status: Recruiting

Location contact

Shanghai Geriatric Medical Center

CONTACT

[email protected]

02164175590

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects aged ≥65 years, with no gender restriction. Patients meet the indications for cardiac surgery (cardiac surgery with cardiopulmonary bypass).

Normal liver and renal function during the screening period. No evidence of active infection during the screening period. Able to cooperate in answering questions related to the MMSE and MoCA cognitive scales during the screening period.

Have signed the informed consent form.

Exclusion criteria

  • The investigator considers that the subject has conditions that may interfere with the study results.

Subjects with evidence of active liver disease (liver function test results: ALT or AST ≥ 2 times the upper limit of normal [ULN]) or chronic active hepatitis B or C within 1 month.

Active systemic infection requiring antibacterial drugs within 1 week before surgery.

Preoperative low MMSE score (illiterate: <17 points; primary school education: <20 points; middle school education or above: <24 points).

Patients with one or more of the following diseases:

Classified as obese (body mass index ≥ 30 kg/m²); Uncontrolled hypertension (defined as systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 100 mmHg); History of organ transplantation, including corneal transplantation; Any clinically significant uncontrolled respiratory disease, including but not limited to chronic obstructive pulmonary disease, asthma, bronchiectasis, or pleural effusion; Previously diagnosed or suspected demyelinating diseases, including multiple sclerosis, Guillain-Barré syndrome, etc.; Use of any glucocorticoids or immunosuppressive agents; Any disease that significantly affects the nervous system. Participation in other clinical trials.

Treatment and study plan

Primary outcomes

  1. Postoperative Cognitive Dysfunction Incidence in Elderly Cardiac Surgery Patients

    Time frame: 7 days post-surgery

Study contacts

Contact information is provided by the study sponsor or research team.

Hao Fang

CONTACT

[email protected]

02164175590

Sponsors and collaborators

Lead sponsor

Shanghai Geriatric Medical Center

Other

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Mar 19, 2026
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.